Skip to content
Sign in

RKDA · NASDAQ

Arcadia Biosciences (RKDA) Stock Price & Fundamentals

$297.43−0.83%−$2.49End-of-day price as of Oct 9, 2026

Arcadia Biosciences (RKDA) closed at $297.43 on Oct 9, 2026, down 0.83% from the previous close of $299.92.

Share price, past year

1Y +4.28%

52-week range $281.29 – $335.50. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$297.43
Sep 30, 2026$297.83
Aug 31, 2026$297.44
Jul 31, 2026$298.14
Jun 30, 2026$313.47
May 29, 2026$329.62
Apr 30, 2026$317.80
Mar 31, 2026$313.22
Feb 27, 2026$311.78
Jan 30, 2026$308.13
Dec 31, 2025$314.38
Nov 28, 2025$305.29
Oct 31, 2025$283.97

Key statistics

Market cap
$648.91M
P/E (TTM)
—
EPS (TTM)
−$4.55
Revenue (TTM)
$4.75M
Net income (TTM)
−$11.13M
Shares outstanding
2.2M
Dividend yield
—
52-week range
$281.29 – $335.50

Arcadia Biosciences's market cap is $648.91M, based on a share price of $297.43 and 2.2M shares outstanding as of Jun 30, 2026.

Financials

Arcadia Biosciences reported revenue of $4.86M for fiscal 2025, down 3.71% from fiscal 2024.

Arcadia Biosciences reported a net loss of $2.34M in fiscal 2025.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Arcadia Biosciences annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$4.86M−3.7%−$2.34M−48.2%−$1.71−$4.70M
FY2024ended Dec 31, 2024$5.05M+13.3%−$7.04M−139.5%−$5.17−$9.64M
FY2023ended Dec 31, 2023$4.45M−40.0%−$13.98M−313.9%−$11.29−$15.30M
FY2022ended Dec 31, 2022$7.42M+9.4%−$15.38M−207.3%−$25.65−$14.05M
FY2021ended Dec 31, 2021$6.78M−15.6%−$14.66M−216.2%−$27.56−$26.88M
FY2020ended Dec 31, 2020$8.03M+587.3%−$4.66M−57.9%−$0.47−$32.55M
FY2019ended Dec 31, 2019$1.17M−20.2%−$28.81M−2,464.1%−$4.53−$18.68M
FY2018ended Dec 31, 2018$1.46M−63.6%−$13.48M−920.8%−$3.58−$13.88M
FY2017ended Dec 31, 2017$4.03M+26.3%−$15.71M−390.1%−$7.28−$14.04M
FY2016ended Dec 31, 2016$3.19M—−$19.62M−615.6%−$8.85—
Arcadia Biosciences quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$1.44M−$6.27M−$2.09
Q1 FY2026ended Mar 31, 2026$1.10M−$4.39M−$2.11
Q4 FY2025ended Dec 31, 2025$901.00K−$1.34M−$0.97
Q3 FY2025ended Sep 30, 2025$1.30M$856.00K$0.62
Q2 FY2025ended Jun 30, 2025$1.46M−$4.46M−$3.26
Q1 FY2025ended Mar 31, 2025$1.20M$2.60M$1.90
Q4 FY2024ended Dec 31, 2024$1.22M−$4.06M−$2.99
Q3 FY2024ended Sep 30, 2024$1.54M−$1.61M−$1.18

Company profile

Name
Arcadia Biosciences, Inc.
Ticker
RKDA
Exchange
NASDAQ
Industry (SEC SIC)
Crude Petroleum & Natural Gas
Headquarters
5956 Sherry Lane, Suite 2000, Dallas, TX
Incorporated in
DE
Fiscal year ends
December
SEC CIK
0001469443

Recent SEC filings

Frequently asked questions

What is Arcadia Biosciences's stock price?

Arcadia Biosciences (RKDA) closed at $297.43 on Oct 9, 2026, down 0.83% from the previous close of $299.92.

What is Arcadia Biosciences's market cap?

Arcadia Biosciences's market cap is $648.91M, based on a share price of $297.43 and 2.2M shares outstanding as of Jun 30, 2026.

How much revenue does Arcadia Biosciences make?

Arcadia Biosciences reported revenue of $4.86M for fiscal 2025, down 3.71% from fiscal 2024.

Does Arcadia Biosciences pay a dividend?

Arcadia Biosciences's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from Arcadia Biosciences, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures